{"disease":{"id":"pgl","name":"pgl"},"drugs":{"marketed":[{"drug_id":"belzutifan","indication_name":"Pheochromocytoma or Paraganglioma (PPGL)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Welireg","generic_name":"BELZUTIFAN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"HIF-2α","drug_class":"Hypoxia-inducible Factor Inhibitor [EPC]","quality_score":75,"revenue":"509","mechanism":"Belzutifan inhibits HIF-2α, blocking its interaction with HIF-1β to reduce expression of genes linked to tumor growth."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05752773","title":"Prediction of Myocardial Injury After Laparoscopic Pheochromocytoma/ParaGangLioma Resection","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07412158","title":"Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT06503146","title":"18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":320,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06870396","title":"National Study of Adrenal Tumours","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Society for Endocrinology","has_results":false},{"nct_id":"NCT07182175","title":"Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":150,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT01371201","title":"First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT07288931","title":"Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}